Han Joo Cho

1.6k total citations
70 papers, 1.2k citations indexed

About

Han Joo Cho is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Han Joo Cho has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Ophthalmology, 48 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Han Joo Cho's work include Retinal Diseases and Treatments (56 papers), Retinal Imaging and Analysis (37 papers) and Glaucoma and retinal disorders (30 papers). Han Joo Cho is often cited by papers focused on Retinal Diseases and Treatments (56 papers), Retinal Imaging and Analysis (37 papers) and Glaucoma and retinal disorders (30 papers). Han Joo Cho collaborates with scholars based in South Korea, United States and Slovakia. Han Joo Cho's co-authors include Chul Gu Kim, Hyoung Seok Kim, Tae Gon Lee, Jong Woo Kim, Jung Il Han, Jae Hui Kim, Jong Woo Kim, Young Ju Lew, Dong Won Lee and Ming Chang Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Han Joo Cho

64 papers receiving 1.2k citations

Peers

Han Joo Cho
Dennis SC Lam Hong Kong
John Kearney United States
Uday R. Desai United States
Raymond R. Margherio United States
Gülcan Kural Türkiye
Eun Jee Chung South Korea
W Xing United Kingdom
Dennis SC Lam Hong Kong
Han Joo Cho
Citations per year, relative to Han Joo Cho Han Joo Cho (= 1×) peers Dennis SC Lam

Countries citing papers authored by Han Joo Cho

Since Specialization
Citations

This map shows the geographic impact of Han Joo Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Joo Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Joo Cho more than expected).

Fields of papers citing papers by Han Joo Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Joo Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Joo Cho. The network helps show where Han Joo Cho may publish in the future.

Co-authorship network of co-authors of Han Joo Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Han Joo Cho. A scholar is included among the top collaborators of Han Joo Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Joo Cho. Han Joo Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cho, Han Joo, et al.. (2023). Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy. Journal of Ocular Pharmacology and Therapeutics. 39(9). 653–660. 3 indexed citations
3.
Kim, Jae‐Min, Hyoung Seok Kim, Su Jin Yoo, et al.. (2022). Immediate Vitrectomy for Acute Endophthalmitis in Patients with a Visual Acuity of Hand Motion or Better. Korean Journal of Ophthalmology. 36(5). 390–397. 5 indexed citations
4.
Cho, Han Joo, et al.. (2021). Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti–Vascular Endothelial Growth Factor Treatment. American Journal of Ophthalmology. 234. 6–14. 10 indexed citations
5.
Cho, Han Joo, et al.. (2021). Nonexudative morphologic changes of neovascularization on optical coherence tomography angiography as predictive factors for exudative recurrence in age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(3). 839–848. 2 indexed citations
6.
Yoon, Jihyun, et al.. (2021). Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization. Scientific Reports. 11(1). 23643–23643. 2 indexed citations
7.
Cho, Han Joo, et al.. (2020). Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. British Journal of Ophthalmology. 104(10). 1443–1447. 11 indexed citations
8.
Cho, Han Joo, et al.. (2019). Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy. Investigative Ophthalmology & Visual Science. 35(3). 174–181. 1 indexed citations
9.
Cho, Han Joo, et al.. (2017). Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 33(6). 452–458. 11 indexed citations
10.
Cho, Han Joo, et al.. (2017). MACULAR EDEMA AFTER CATARACT SURGERY IN EYES WITH PREOPERATIVE RETINAL VEIN OCCLUSION. Retina. 38(6). 1180–1186. 13 indexed citations
11.
Cho, Han Joo, et al.. (2017). INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB INJECTIONS FOR TYPE 3 NEOVASCULARIZATION. Retina. 38(11). 2150–2158. 17 indexed citations
12.
Bae, Kunho, et al.. (2016). Optical Coherence Tomographic Features and Prognosis of Pneumatic Displacement for Submacular Hemorrhage. PLoS ONE. 11(12). e0168474–e0168474. 12 indexed citations
13.
Cho, Han Joo, Tae Gon Lee, Sang Youn Han, et al.. (2015). Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Graefe s Archive for Clinical and Experimental Ophthalmology. 254(1). 23–30. 29 indexed citations
14.
Cho, Han Joo, et al.. (2014). Intravitreal Ranibizumab Injections with and without Pneumatic Displacement for Treating Submacular Hemorrhage Secondary to Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 55(13). 4967–4967. 1 indexed citations
15.
Cho, Han Joo, Hyoung Seok Kim, Jae Hui Kim, et al.. (2014). Risk Factors for Geographic Atrophy After Intravitreal Ranibizumab Injections for Retinal Angiomatous Proliferation. American Journal of Ophthalmology. 159(2). 285–292.e1. 79 indexed citations
16.
17.
Kim, Jae Hui, Young Suk Chang, Jong Woo Kim, et al.. (2013). Intravitreal Anti-Vascular Endothelial Growth Factor for Submacular Hemorrhage from Choroidal Neovascularization. Ophthalmology. 121(4). 926–935. 67 indexed citations
18.
19.
Cho, Han Joo, et al.. (2013). Anti–Vascular Endothelial Growth Factor Monotherapy in the Treatment of Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy. American Journal of Ophthalmology. 156(3). 524–531.e1. 30 indexed citations
20.
Cho, Han Joo, Hyoung Seok Kim, Jung Il Han, et al.. (2013). Effects of Choroidal Vascular Hyperpermeability on Anti–Vascular Endothelial Growth Factor Treatment for Polypoidal Choroidal Vasculopathy. American Journal of Ophthalmology. 156(6). 1192–1200.e1. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026